Home
HelpTest ID KI67B Ki-67(MIB-1), Breast, Quantitative Immunohistochemistry, Automated
Ordering Guidance
Ki-67 immunohistochemistry testing on intracystic papillary carcinoma and solid papillary carcinoma, without clearly stating invasive carcinoma, is not appropriate and will be canceled without processing.
If ordering for diagnostic purposes, order PATHC / Pathology Consultation and request the stain.
Shipping Instructions
Attach the green pathology address label included in the kit to the outside of the transport container.
Necessary Information
1. Pathologist's name, address, and phone number are required.
2. Include accompanying pathology report stating the final diagnosis. If not available, a preliminary diagnosis is acceptable only if it refers to invasive or metastatic breast carcinoma.
Specimen Required
Supplies: Pathology Packaging Kit (T554)
Specimen Type: Preferred: Formalin-fixed, paraffin-embedded tissue block containing invasive or metastatic breast carcinoma
Acceptable: 2 Unstained sections, containing invasive or metastatic breast carcinoma, on charged slides cut at 4 microns less than 1 month ago. Tissue on the slides should have been fixed in 10% neutral buffered formalin. Also send one hematoxylin and eosin-stained slide if possible.
Submission Container/Tube: Pathology Packaging Kit
Collection Instructions: Submit paraffin-embedded invasive or metastatic breast carcinoma tissue.
Additional Information: Paraffin block will be returned with the final report.
Forms
If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
-Oncology Test Request (T729)
-Immunohistochemical (IHC)/In Situ Hybridization (ISH) Stains Request (T763)
Useful For
Determining proliferation of tumor cells in paraffin-embedded tissue blocks from patients diagnosed with breast carcinoma
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| KIBM | Ki67 Breast IHC Manual | No | No |
Testing Algorithm
Cases that are not able to be scanned for automated analysis will be changed to the manual process for analysis.
Method Name
Immunohistochemistry, Automated Quantitation
Reporting Name
Ki67 Breast IHC AutomatedSpecimen Type
SpecialSpecimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Special | Ambient (preferred) | ||
| Refrigerated | |||
Reference Values
Varies by tumor type; values reported from 0% to 100%
Day(s) Performed
Monday through Friday
Report Available
4 to 6 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88361
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| KI67B | Ki67 Breast IHC Automated | 85330-9 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 70995 | Interpretation | 85330-9 |
| 70996 | Participated in the Interpretation | No LOINC Needed |
| 70997 | Report electronically signed by | 19139-5 |
| 70999 | Material Received | 81178-6 |
| MA023 | Tumor type | 44638-5 |
| MA024 | Tumor classification | 21918-8 |
| 71627 | Disclaimer | 62364-5 |
| 71841 | Case Number | 80398-1 |